IM Cannabis Corp. enters into LOI to sell European assets
The transaction is expected to reduce debt by CAD$10.5 million and streamline operations.
See the latest news and media coverage for IMC. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical cannabis company
imcannabis.comLast updated
In short: IMC signed a letter of intent to sell its European assets for $10.5 million and reported 2025 revenue of C$54.7 million with positive cash flow.
The transaction is expected to reduce debt by CAD$10.5 million and streamline operations.
The statement registers over 17 million common shares issuable upon conversion of notes and warrants.
Revenue of $8.7 million, operating loss of $1.7 million, net loss of $2.5 million.
The company has 180 days to regain compliance; the notice does not affect current listing or trading.
IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC), a medical cannabis company with operations in Israel and Germany, is pleased to announce that it...
"Q1 2025 is a clear inflection point for IMC," said Oren Shuster, Chief Executive Officer of IMC. "Achieving net profitability and an 87% improvement in...
TORONTO and GLIL YAM, Israel, Oct. 2, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical...
TORONTO and GLIL YAM, Israel, July 29, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical...
Track IMC and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to IMC and other trending companies.